Dermal extracellular matrix (dECM) (dECM)

The dermal extracellular matrix (ECM) is a complex, three-dimensional network of macromolecules that provides the structural scaffold and biochemical signaling environment for skin cells. It is primarily composed of fibrillar proteins such as Type I and III collagens and elastin, which confer tensile strength and elasticity, alongside proteoglycans and glycoproteins that regulate hydration and cell-matrix interactions. This structural niche is essential for maintaining skin homeostasis, guiding cellular processes like migration and differentiation, and facilitating effective wound repair. Dysregulation of the dermal ECM is central to various pathologies: its excessive accumulation leads to fibrosis and keloids, while its degradation by matrix metalloproteinases (MMPs) is a hallmark of skin aging and chronic wounds. In oncology, the remodeling of the dermal ECM can create a pro-tumorigenic niche that supports the invasion and metastasis of skin cancers such as melanoma and squamous cell carcinoma. Therapeutic strategies targeting this niche include the use of retinoids to stimulate collagen synthesis, MMP inhibitors to prevent matrix breakdown, and enzymatic agents like collagenase to treat fibrotic conditions.

Other names

Dermal ECMDermal matrisomeInterstitial dermal matrixDermal extracellular matrix structural nicheDermal microenvironment

Drugs targeting the dermal extracellular matrix act by stimulating the synthesis of structural proteins like collagen and elastin, inhibiting degradative enzymes such as matrix metalloproteinases (MMPs), or enzymatically breaking down excessive matrix components in fibrotic conditions.